Reuters reported the company.Cansino BiologyohChina Posted on the company’s social media accounts late Thursday night (January 5), the vaccine known as CS-2034 Targeting new strains of omikron That caused massive infections after China canceled the policyzero covidStrictly in Dec.
To this day, China still uses nine self-developed vaccines, including the inactive vaccine. But none of them are improved to cope with the species.Omicronwho are easier to contact, including children who are currently in the epidemic
booster vaccineohcasinoIt is one of China’s first promising vaccines.mRNA technology The same goes for foreign vaccines such as Pfizer-Biontech and Moderna.
Cansino also reported in its filing with the Hong Kong Stock Exchange that Preliminary data from intermediate technical trials of the vaccine show good results. mRNA vaccine production The first phase can produce 100 million doses.
